390 related articles for article (PubMed ID: 11040107)
21. In vivo deposition of myosin-specific autoantibodies in the hearts of mice with experimental autoimmune myocarditis.
Neumann DA; Lane JR; Wulff SM; Allen GS; LaFond-Walker A; Herskowitz A; Rose NR
J Immunol; 1992 Jun; 148(12):3806-13. PubMed ID: 1602130
[TBL] [Abstract][Full Text] [Related]
22. Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy.
Caforio AL; Tona F; Bottaro S; Vinci A; Dequal G; Daliento L; Thiene G; Iliceto S
Autoimmunity; 2008 Feb; 41(1):35-45. PubMed ID: 18176863
[TBL] [Abstract][Full Text] [Related]
23. Osteoprotegerin/RANK/RANKL axis in cardiac remodeling due to immuno-inflammatory myocardial disease.
Liu W; Feng W; Wang F; Li W; Gao C; Zhou B; Ma M
Exp Mol Pathol; 2008 Jun; 84(3):213-7. PubMed ID: 18417124
[TBL] [Abstract][Full Text] [Related]
24. Overt expression of AP-1 reduces alpha myosin heavy chain expression and contributes to heart failure from chronic volume overload.
Freire G; Ocampo C; Ilbawi N; Griffin AJ; Gupta M
J Mol Cell Cardiol; 2007 Oct; 43(4):465-78. PubMed ID: 17720185
[TBL] [Abstract][Full Text] [Related]
25. Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state.
Sun M; Chen M; Dawood F; Zurawska U; Li JY; Parker T; Kassiri Z; Kirshenbaum LA; Arnold M; Khokha R; Liu PP
Circulation; 2007 Mar; 115(11):1398-407. PubMed ID: 17353445
[TBL] [Abstract][Full Text] [Related]
26. A CCR1 antagonist prevents the development of experimental autoimmune myocarditis in association with T cell inactivation.
Futamatsu H; Suzuki J; Koga N; Adachi S; Kosuge H; Maejima Y; Haga T; Hirao K; Horuk R; Isobe M
J Mol Cell Cardiol; 2006 Jun; 40(6):853-61. PubMed ID: 16698032
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin II type 1 receptor blocker, valsartan, prevented cardiac fibrosis in rat cardiomyopathy after autoimmune myocarditis.
Tachikawa H; Kodama M; Hui L; Yoshida T; Hayashi M; Abe S; Kashimura T; Kato K; Hanawa H; Watanabe K; Nakazawa M; Aizawa Y
J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S105-10. PubMed ID: 12688405
[TBL] [Abstract][Full Text] [Related]
28. Brain natriuretic peptide appears to act locally as an antifibrotic factor in the heart.
Ogawa Y; Tamura N; Chusho H; Nakao K
Can J Physiol Pharmacol; 2001 Aug; 79(8):723-9. PubMed ID: 11558681
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance and pathogenic role of anti-cardiac myosin autoantibody in dilated cardiomyopathy.
Wang Z; Liao Y; Dong J; Li S; Wang J; Fu ML
Chin Med J (Engl); 2003 Apr; 116(4):499-502. PubMed ID: 12875710
[TBL] [Abstract][Full Text] [Related]
30. Amiodarone improves cardiac sympathetic nerve function to hold norepinephrine in the heart, prevents left ventricular remodeling, and improves cardiac function in rat dilated cardiomyopathy.
Tachikawa H; Kodama M; Watanabe K; Takahashi T; Ma M; Kashimura T; Ito M; Hirono S; Okura Y; Kato K; Hanawa H; Aizawa Y
Circulation; 2005 Feb; 111(7):894-9. PubMed ID: 15710769
[TBL] [Abstract][Full Text] [Related]
31. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
Gao S; Long CL; Wang RH; Wang H
Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
[TBL] [Abstract][Full Text] [Related]
32. Autoantibodies to cardiac myosin in mouse cytomegalovirus myocarditis.
O'Donoghue HL; Lawson CM; Reed WD
Immunology; 1990 Sep; 71(1):20-8. PubMed ID: 2170269
[TBL] [Abstract][Full Text] [Related]
33. Effect of combination therapy with OK432 and recombinant human interferon-alpha A/D on atrial natriuretic peptide gene expression in mice with viral myocarditis.
Kanda T; Yokoyama T; Imai S; Suzuki T; Murata K; Kobayashi I
J Pharmacol Exp Ther; 1995 Jul; 274(1):494-8. PubMed ID: 7616436
[TBL] [Abstract][Full Text] [Related]
34. Pioglitazone, a peroxisome proliferator-activated receptor gamma activator, ameliorates experimental autoimmune myocarditis by modulating Th1/Th2 balance.
Hasegawa H; Takano H; Zou Y; Qin Y; Hizukuri K; Odaka K; Toyozaki T; Komuro I
J Mol Cell Cardiol; 2005 Feb; 38(2):257-65. PubMed ID: 15698832
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of cyclooxygenase-2 enhances myocardial damage in a mouse model of viral myocarditis.
Takahashi T; Zhu SJ; Sumino H; Saegusa S; Nakahashi T; Iwai K; Morimoto S; Kanda T
Life Sci; 2005 Nov; 78(2):195-204. PubMed ID: 16107267
[TBL] [Abstract][Full Text] [Related]
36. Role of the cholinergic antiinflammatory pathway in murine autoimmune myocarditis.
Leib C; Göser S; Lüthje D; Öttl R; Tretter T; Lasitschka F; Zittrich S; Pfitzer G; Katus HA; Kaya Z
Circ Res; 2011 Jul; 109(2):130-40. PubMed ID: 21597011
[TBL] [Abstract][Full Text] [Related]
37. Cellular infiltrate, major histocompatibility antigen expression and immunopathogenic mechanisms in cardiac myosin-induced myocarditis.
Pummerer C; Berger P; Frühwirth M; Ofner C; Neu N
Lab Invest; 1991 Nov; 65(5):538-47. PubMed ID: 1753703
[TBL] [Abstract][Full Text] [Related]
38. Reduced-energy diet improves survival of obese KKAy mice with viral myocarditis: induction of cardiac adiponectin expression.
Kanda T; Saegusa S; Takahashi T; Sumino H; Morimoto S; Nakahashi T; Iwai K; Matsumoto M
Int J Cardiol; 2007 Jul; 119(3):310-8. PubMed ID: 17275107
[TBL] [Abstract][Full Text] [Related]
39. Cardiac troponin I but not cardiac troponin T induces severe autoimmune inflammation in the myocardium.
Göser S; Andrassy M; Buss SJ; Leuschner F; Volz CH; Ottl R; Zittrich S; Blaudeck N; Hardt SE; Pfitzer G; Rose NR; Katus HA; Kaya Z
Circulation; 2006 Oct; 114(16):1693-702. PubMed ID: 17015788
[TBL] [Abstract][Full Text] [Related]
40. Effects of atorvastatin on the Th1/Th2 polarization of ongoing experimental autoimmune myocarditis in Lewis rats.
Liu W; Li WM; Gao C; Sun NL
J Autoimmun; 2005 Dec; 25(4):258-63. PubMed ID: 16242301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
